SCHEMBL2718684

SCHEMBL2718684

C[C@H](NN)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29089183 1.00
SCHEMBL23019171 1.00
SCHEMBL11774866 0.78 LMNA (0.35)
SCHEMBL9523940 0.77
SCHEMBL3818445 0.77
SCHEMBL3868009 0.75
SCHEMBL372686 0.75
SCHEMBL372687 0.75
SCHEMBL300789 0.75
SCHEMBL16542404 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445866-A2 MEXILETINE AMINO ACID AND PEPTIDE PRODRUGS AND USES THEREOF Shire LLC (US) 2012-05-02 EP claimed
US-20110028552-A1 MEXILETINE AMINO ACID AND PEPTIDE PRODRUGS AND USES THEREOF SHIRE LLC 2011-02-03 US claimed
WO-2010149760-A2 MEXILETINE AMINO ACID AND PEPTIDE PRODRUGS AND USES THEREOF SHIRE LLC (US) 2010-12-29 WO claimed
EP-3661938-B1 NOVEL METHOD FOR SYNTHESIZING AMANITINS HEIDELBERG PHARMA RES GMBH (DE) 2025-01-15 EP disclosed
US-11926631-B2 Method of treating cancer using amanitin derivatives HEIDELBERG PHARMA RESEARCH GMBH (DE) 2024-03-12 US disclosed
US-20220274995-A1 NOVEL METHOD FOR SYNTHESIZING AMANITINS HEIDELBERG PHARMA RESEARCH GMBH (DE) 2022-09-01 US disclosed
US-11420971-B2 Method for synthesizing amanitins HEIDELBERG PHARMA RESEARCH GMBH (DE) 2022-08-23 US disclosed
EP-2940008-A1 NOVEL BENZAZEPINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF Sanwa Kagaku Kenkyusho Co., Ltd (JP) 2015-11-04 EP disclosed
US-20120196933-A1 MEXILETINE PRODRUGS FRANKLIN RICHARD (GB) 2012-08-02 US disclosed